ML
Mark Lin
Assistant Professor of Medicine, University of Arizona, Tuscon, AZ · Washington University/B-JH/SLCH Consortium
Credentials: · · · · ·
History
- 2004–2007
Internal Medicine
- 2000–2004
Research
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation
New England Journal of Medicine · 2023 · 280 citations
Genomic polymorphisms in sepsis
Review · Critical Care Medicine · 2004 · First of 2 authors · 130 citations
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
Nature Medicine · 2024 · 125 citations
- AS
3 papers
- EM
3 papers
- JS
3 papers
3 papers
- ND
3 papers
3 papers
2 papers
- KA
2 papers
